TransCode Therapeutics (NASDAQ:RNAZ) Given New $20.00 Price Target at HC Wainwright
TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) had its price target lifted by stock analysts at HC Wainwright from $3.00 to $20.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective would indicate a potential upside of 463.38% […]
More Stories
Tempus AI (NASDAQ:TEM) Sees Unusually-High Trading Volume – Still a Buy?
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) shares saw an uptick in trading volume on Wednesday . 1,687,457 shares...
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 4.9% – Here’s Why
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) rose 4.9% during trading on Wednesday . The stock...
TIM (NYSE:TIMB) Shares Gap Down – Time to Sell?
Tim S.A. (NYSE:TIMB – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously...
SoundHound AI (NASDAQ:SOUN) Sees Unusually-High Trading Volume – Should You Buy?
Shares of SoundHound AI, Inc. (NASDAQ:SOUN – Get Free Report) saw strong trading volume on Wednesday . 26,469,053 shares were...
Red Cat (NASDAQ:RCAT) Trading Down 5.7% – Should You Sell?
Red Cat Holdings, Inc. (NASDAQ:RCAT – Get Free Report) shares traded down 5.7% on Wednesday . The stock traded as...
US Car Sales Forecast to Beat Expectations for Best Performance Since 2019
By Naveen Athrappully U.S. car sale numbers for 2024 are expected to break previous years’ figures, with better buying conditions...